MetLife Investment Management, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$21,691
-90.0%
13,642
-60.7%
0.00%
-100.0%
Q4 2022$216,094
-7.0%
34,6860.0%0.00%0.0%
Q3 2022$232,396
+22.8%
34,686
+16.5%
0.00%0.0%
Q2 2022$189,280
+16.2%
29,761
-15.2%
0.00%
+100.0%
Q1 2022$162,910
+129.4%
35,110
+495.7%
0.00%0.0%
Q3 2021$71,023
-73.5%
5,894
-53.5%
0.00%
-66.7%
Q2 2021$268,309
-24.6%
12,6860.0%0.00%0.0%
Q1 2021$355,842
+7.9%
12,6860.0%0.00%0.0%
Q4 2020$329,836
-30.1%
12,6860.0%0.00%
-40.0%
Q3 2020$471,539
-27.6%
12,6860.0%0.01%
-28.6%
Q2 2020$650,919
+89.4%
12,686
+16.4%
0.01%
+40.0%
Q1 2020$343,709
-47.1%
10,9010.0%0.01%
-28.6%
Q4 2019$650,027
+62.7%
10,9010.0%0.01%
+40.0%
Q3 2019$399,631
-21.2%
10,9010.0%0.01%
-16.7%
Q2 2019$507,115
+15.9%
10,9010.0%0.01%
+20.0%
Q1 2019$437,675
-12.7%
10,9010.0%0.01%
-16.7%
Q4 2018$501,446
+3.7%
10,9010.0%0.01%
+20.0%
Q3 2018$483,677
+13.3%
10,9010.0%0.01%0.0%
Q2 2018$427,000
-21.7%
10,901
+44.6%
0.01%
-16.7%
Q1 2018$545,000
+9.9%
7,5380.0%0.01%0.0%
Q4 2017$496,0007,5380.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2018
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$27,840,84218.82%
Ikarian Capital, LLC 1,891,147$11,781,8462.84%
Altium Capital Management LP 620,000$3,862,6001.96%
Ikarian Capital, LLC 1,296,900$8,079,6871.95%
Parkman Healthcare Partners LLC 822,784$5,125,9441.36%
Deep Track Capital, LP 4,000,000$24,920,0001.05%
Monaco Asset Management SAM 470,100$2,928,7230.88%
BRAIDWELL LP 3,393,405$21,140,9130.71%
Telemetry Investments, L.L.C. 71,000$4420.70%
Rhenman & Partners Asset Management AB 900,000$5,607,0000.58%
View complete list of ESPERION THERAPEUTICS INC NE shareholders